2018


Hyperfractionated reirradiation with cetuximab for recurrent head and neck cancer: The GORTEC 2008-01 multicentric phase II study.

Mathilde Saint-Ghislain, Yungan Tao, Marc Alfonsi, Pierre Boisselier, Muriel Garcia-Ramirez, Claude Tuchais, Philippe Maingon, Christian Sire, Ali Hasbini, Marie Saliou, Cedrik Lafond, Hao Qiu, Sébastien Guihard, Pascal Garaud, marie-Helene Calais, Juliette Thariat, Laurent Martin, Jean Bourhis

J Clin Oncol 36, 2018 (suppl; abstr 6034)